A biotech firm founded by Vivek Ramaswamy turned $15 million into $5 billion by flipping a bowel-disease treatment that Pfizer gave it for free
Conservative entrepreneur Vivek RamaswamyScott Olson/Getty PicturesRoche acquired a bowel-disease therapy from Roivant…
